Thomas B. Neff, Chief Executive Officer at FIBROGEN INC (FGEN), sold 39,636 shares at $38.29 ($1.6M) on 2018-11-20, disclosed to the SEC on 2018-11-21.
Scheduled sale ($1.6M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $38.29 | 2,700 | $103K | 6.6% |
| 2 | $39.20 | 818 | $32K | 2.1% |
| 3 | $39.41 | 15,800 | $623K | 39.9% |
| 4 | $39.65 | 100 | $4K | 0.3% |
| 5 | $39.95 | 400 | $16K | 1.0% |
| 6 | $39.47 | 918 |
| $36K |
| 2.3% |
| 7 | $39.47 | 18,900 | $746K | 47.8% |
| Total | $39.37 avg | 39,636 | $1.6M | 100% |
| Filing → |
| FGEN | SELL | 2019-07-26 | $1.9M | — | Filing → |
| FGEN | SELL | 2019-07-12 | $1.8M | — | Filing → |
| FGEN | SELL | 2019-06-21 | $1.8M | — | Filing → |